COVID vaccine acceptance in Libya
Willingness to take a COVID-19 vaccine rose with assumed efficacy—about 80% if efficacy was ≥90%, but only about 41% if 50%.
Source
Knowledge, attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: a cross-sectional study
Study at a glance
- Design
- Cross-sectional — Survey of public and health-care groups in Libya on COVID-19 vaccine acceptance by efficacy scenario
- N
- N=15087 · Final analysed respondents; mean age 30.6 years
- Population
- Libyan general public, students, and clinicians
- Outcome
- Willingness to accept COVID-19 vaccination at ≥90%, ≥70%, and 50% efficacy
Structured fields used in claim comparison tables when every cited study has a complete layer.
Inspect source passages
COVID vaccine acceptance in Libya
These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.
79.6% would take a ≥90% efficacy vaccine.
For vaccine acceptance and efficacy, 12,006 (79.6%) reported willingness to take the vaccine with an efficacy of 90% or more, 9143 (60.6%) with an efficacy of 70% or more, and only 6212 (41.2%) with an efficacy of 50%.
Who was in the sample?
Among the participants, 11,120 (73.7%) were from the general population, 1752 (11.6%) were medical students, 1394 (9.2%) were medical doctors, and 821 (5.4%) were paramedics or nurses.
What they did
A cross-sectional survey of the public and health-care groups in Libya assessed knowledge, attitudes, and acceptance of COVID-19 vaccination under different efficacy scenarios.
What they found
Among 15,087 respondents, acceptance was 79.6% for ≥90% efficacy, 60.6% for ≥70%, and 41.2% for 50%. Most respondents were general public; about one-quarter were students or clinicians.
The limits
What it doesn't show
Convenience/online sampling and hypothetical efficacy scenarios limit inference about later real uptake.
Key terms
- Vaccine acceptance
- Willingness to take a COVID-19 vaccine.
- Efficacy scenario
- Assumed vaccine effectiveness presented to respondents.
- KAP survey
- Knowledge, attitude, and practice/acceptance questionnaire.
- Health-care workers
- Doctors, nurses/paramedics, and medical students in the sample.
- Cross-sectional
- Single-time survey design.
- General population
- Non–health-worker respondents.
Flashcards
0 of 10 answers reviewed
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
N analysed:
Common questions
N analysed?
15,087.
Acceptance if ≥90% efficacy?
79.6%.
Acceptance if 50% efficacy?
41.2%.
Share general public?
73.7%.
More on Vaccination